Herpes viral infection treatment

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31415

Patent

active

039521036

ABSTRACT:
The administration internally to humans of 1-(.beta.-hydroxethyl)-2-methyl-5-nitromidazole, (metronidazole) in a dosage range for adult humans of about 31 to 1,000 mgs per twenty-four hour period, is an effective therapeutic treatment certain of viral infections.

REFERENCES:
the Merck Manual, 12 Ed., 1972, Merck & Co., Inc. Rahway, N.J., pp. 18t-21t.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Herpes viral infection treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Herpes viral infection treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes viral infection treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1588446

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.